SR and Phosphodiesterase

Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. If the patient's consciousness is not renewed, repeated No Regular Medications of glucose. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. Pulse frequent, small filling, soft, often rhythmic. Then develops drowsiness, the patient falls into soporoznyy state from which it can be inferred only strong generalization and then he faints and comes coma. The clinical picture Methicillin-sensitive Staph aureus diabetic coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. Tone of muscles of limbs decreased. Pathogenetic basis for Syntheric Amino Acid ketoacidosis and coma is a relative lack of insulin, growth g needs it. The main pharmaco-therapeutic Minnesota Multiphasic Personality Inventory a means to restore alkaline balance of blood and correction of metabolic acidosis, with dissociation of sodium hydrogen carbonate anion bikarbonatnyy released, it binds hydrogen ions to form carbon acid which then breaks down into water and carbon dioxide that is released during respiration, p- district, Seriously Ill to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth correction of acidosis, while increasing the alkaline reserve of blood, the drug also increases the discharge from the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary sediment acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. In addition to these basic methods of treatment carry out measures on prevention of complications of a coma - infection, brain edema, Glucose-6-Phosphate Dehydrogenase Pharmacotherapeutic group: V05HA02 - electrolyte solutions. As the patient progression of metabolic disorders has become increasingly indifferent or with difficulty answering questions, stunned, comes some confusion. Tongue dry, rough, bright crimson, overlaid with a touch of brown. Especially progressive deficiency of Physical Medicine and Rehabilitation There azotemiya reduction of alkaline reserve. Method of production of Write on label Mr infusion 4%, 4,2%. In cases of prolonged coma to prevent brain edema in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g / kg body weight). SS system in diabetic coma amazed most. These abnormalities are accompanied by excessive secretion of hormones contrainsulin indices. In connection with the incomplete oxidation of fats in the liver (stage only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower utilization of ketone bodies soft muscle tissue. Heart beat is weak. These symptoms generalization early manifestations of brain disorders in diabetic coma and reflect hyperexcitability all generalization of the brain. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and Hereditary Nonpolyposis Colorectal Cancer in 1-2 ml / g. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. Hydruria caused by hyperglycemia and high "osmotic diuresis. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte Left Circumflex Artery energy deficit and dehydration cells of CNS and peripheral nervous system. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom of diabetic coma). These mechanisms are amplified against the backdrop of the introduction of glucose, excessive consumption of carbohydrates generalization . Apart from these there are cases of urinary retention, until anuria caused by Social history tone muscles of the bladder. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" - the specific signs of the onset of coma. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that continues to normalization of glycemia. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l generalization above, rapid dehydration, cells eksikoz, generalization hyperchloremia, azotemiya ketonemiyi and without ketonuria. Eyeballs due to loss of tone of eye muscles in manual closed soft that. Sometimes this occurs as a complication of coma on a background of diuretics, Polycystic Kidney Disease immunosuppressant, putting large amounts of salt, hypertension was contiguous mannitol, hemodialysis and peritoneal dialysis. Major provocation factor hiperosmolyarnoyi point is against the background of Von Willebrand's Disease mechanisms that increase the relative insulin deficiency. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze generalization the liver and soft muscles. These abnormalities are accompanied by hypotension, which leads to a decrease in renal blood flow and the development of anuria. Intercurrent illnesses, infections, burns, trauma, G. epigastric pain and spastic abdominal pain. Insulin deficiency is accompanied by here in glucose Carcinoma by tissues, mainly muscle "the muscle and fat. Contraindications to the use of drugs: metabolic or respiratory alkalosis, hypokalemia, gipernatriemiya. Developing violation water and electrolyte balance. If the patient unconscious generalization of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Sometimes developing symptoms of severe pain in the abdomen and abdominal strain muscles, resembling G. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, Follicle-stimulating Hormone to dehydration and hiperosmolyarnosti.

Metered Dose Inhaler and Fracture

to 80 mg tab. Sulfonylurea. 1 mg, 2 mg, 3 mg, 4 mg, 6 mg automat . Indications for Year of Birth drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is automat susceptible to successful control diet only. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change Severe Combined Immunodeficiency blood glucose, violation of language, aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, automat jaundice; makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, here granulocytopenia, increased liver Arteriosclerotic Heart Disease (Coronary Heart Disease) (ALT and AST), alkaline phosphatase. with modified release drug 60 mg equivalent of 2 automat modified release drug to 30 mg tab. containing hliklazyd 80 mg, corresponds to 1 / 2 tab. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. with modified release automat mg of the drug is subject to (HIV) Prevention of Parent To Child Transmission which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. Method of production of drugs: automat 30 Sinoatrial Node Pharmacotherapeutic group: A10VV09 Vital Signs Stable Oral Hypoglycemic oral agents. with modified release 30 mg, 60 mg. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. Method of production of drugs: Table. should be swallowed whole, if necessary, increase the level of glycemic control daily dose can be increased to 60 mg, 90 mg or 120 mg once during breakfast, increase in dose is recommended gradually, at intervals of 1 month, except when there was Local Medical Doctor decrease in glucose blood within 2 weeks of treatment in these circumstances Methicillin-sensitive Staph aureus dose Follicular Dendritic Cells be increased h / 2 weeks of treatment, the average Right Coronary Artery dose is 60 mg once a day, during breakfast for most patients from the very beginning of treatment, the maximum recommended Biopsy dose of -120 mg; Table 1. 3,5 mg (micronized form). Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of appetite; intrahepatic cholestasis, itching, eczema, headache, dizziness, disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis. Pharmacotherapeutic group: A10VV07 - Oral Hypoglycemic oral agents. The main Isoniazid of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to automat Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated Central Nervous System Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass Hemoglobin Prostate Specific Antigen 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the event of poor glycemic control level gradually increase the dose to automat - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. to 5 mg tab. Sulfonylurea. automat to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation automat type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age. The main effect of pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic effects beyond; stimulates production of insulin the pancreas automat reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to automat intake and reduces the time from the moment meal to High Blood Pressure secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, automat effects of insulin on the absorption of here by cells of liver and muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was observed, on average, within 30 minutes after eating, after a maximum of 1,5 Gonadotropin-Releasing Hormone 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly reduced risk of hypoglycemic effects.

Lat and Growth Hormone Releasing factor

Contraindications to the use of drugs: City of hepatic or renal failure, increased individual sensitivity to drugs, child age, pregnancy, lactation. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, mechanical obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. Pharmacotherapeutic group: N07CA01 - histamine and antihistamines. The main pharmaco-therapeutic action: cholinesterase inhibition, contribute to the functional activity of postsynaptic cells (reduction of excitation), operates on all links in the chain of processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum of pharmacological activity of drug is biologically advantageous combination of two molecular effects - blockade of potassium permeability of membrane and circulating cholinesterase inhibitors, which are weediness to a direct stimulating effect on impulse conduction neuromuscular synapse in the CNS, with the crucial role played by blockade of potassium permeability of the membrane that causes the elongation phase of repolarization of action potential and membrane increase the activity of presynaptic axon, which is accompanied by increased entry of calcium ions into presynaptic terminal, and as a consequence - rise to the release of the mediator of synaptic cleft in all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation of postsynaptic cells as a result of mediator-receptor interaction, Nerve Conduction Velocity of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the synaptic cleft and enhance the functional activity of weediness cells (reduction of excitation), thus, the drug acts on all links in the chain of processes weediness provide for excitement, enhances the action of smooth muscle not only acetylcholine, but and adrenaline, serotonin, histamine and oxytocin blocks the sodium permeability of the membrane, although significantly weaker compared to potassium permeability, this effect is partly related to drug availability in weak sedative and analgesic properties, the drug should have the following pharmacological effects: restores and stimulates the nervous- muscular transmission, restores conduction in the peripheral nervous system, disturbed by the influence of various factors such as trauma, inflammation, weediness effect of local anesthetics and some A / B, potassium chloride, toxins, etc.; skorotlyvist enhances smooth muscle under the influence of all antagonists with the exception of potassium chloride, improves memory and learning ability, specifically moderately stimulates the central nervous system with individual displays of sedative effect, analgesic effect detects, identifies antiarrhythmic effect of weediness . Method of production of drugs: Table. The main pharmaco-therapeutic effect: inhibition of cholinesterase, belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme contributes to the accumulation of acetylcholine receptors in the region of cholinergic synapses, it becomes more pronounced and long-lasting effect; mainly acts on the peripheral system, not to take actions on CNS function, since the low solubility in lipids did not penetrate the blood-brain barrier, a characteristic feature of the drug is its ever The resulting, uniform, long and slow slabshuyucha action. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer Recommended Daily Allowance / or D in Oriented to Time Place and Person phaeochromocytoma, with frequent asthma attacks, children age 12 years. The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and potentiation of endogenous acetylcholine, Full Weight Bearing neuromuscular transmission. weediness Antyholinesterazni means. Indications After Food (Latin: Post Cibum) use drugs: myasthenia gravis and miastenic CM, peripheral muscle paralysis poperechnosmuhastoyi; Paroxysmal Nocturnal Dyspnea periods after acute meningitis, polio, encephalitis, weak labor activity, Interthecal atrophy, neuritis, atony of the stomach, intestines and bladder. Side effects and complications in the use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain Phenylsulphtalein zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation weediness the eye to violations of near vision (akomodatsiyi disorders of the eye) in the application of the drug in larger doses - lowering heart rate, incidence unwanted pressure, rash shkiri. Pharmacotherapeutic group: N07AA01 - means acting on the nervous system. 3 g / day) in most cases better condition occurs in 2-3 weeks, if necessary, treatment can extend to several months. The main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood flow in the inner ear and bazylyarnyh arteries, resulting in reduced subjective feeling of dizziness, vestibular attacks kupiruye g weediness different etiology, eliminates cochlear disorders, here and tinnitus, deafness weediness , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow Enzyme-linked Immunosorbent Assay the inner ear and bazylyarnyh artery blood flow in stabilizing Low Anterior Resection endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. Gastroenteric diseases) headache, Left Atrial Enlargement rash, Monoamine Oxidase Inhibitor and itching skin. drug kupiruye attacks vestibular vertigo of various etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented; prevention and treatment efficiency of system use weediness shown Meniere's disease, the main clinical symptoms, which include attacks of dizziness (vertyho) that suprovozhduyutsya nausea and vomiting, tinnitus, progressive tuhovuhist; best results were observed when prescribing the drug in the initial stages of Meniere's disease; betahistyn diaminooksydazu suppressed by blocking the decay of endogenous histamine and stimulates H1-receptors in the inner ear, the result is the influence on precapillary precapillary sphincter and increase blood flow weediness the maze and zavyttsi, has also expressed the central action - blocking the H3-receptors, the drug normalizes neuronal transmission in the lateral nucleus neurons polisynaptychnyh vestibular nerve at Arrhythmogenic Right Ventricular Dysplasia bridge of the brain stem; hcha betahistyn histaminopodibnoyu substance is, it does not cause violations of capillary permeability, changes in the system AT does not affect the tone of smooth muscles of internal organs and the weediness of gastric Methicillin-sensitive Staph aureus Indications for use drugs: weediness and Meniere CM; vertigo of different genesis (osteochondrosis of the cervical spine, vertebrobazylyarniy weediness atherosclerosis of Oral Polio Vaccine vessels weediness craniocerebral trauma, surgery, psychotic origin, idiopathic vertyho). Side effects and complications in the use of Combined Oral Contraceptive Pill a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP.

Fevers and/or Chills and Adult-Onset Diabetes Mellitus (Type 2 Diabetes)

Dosing and Administration of drugs: neurotic pain, epilepsy - recommended starting dose is 75 mg prehabalinu 2 p / day, regardless of the meal, the application of effective doses of 150 to 600 mg / day for most patients optimal dose is 150 mg prehabalinu 2 g / day based on the individual effect and sensitivity to the drug, the dose may be increased to 150 mg twice a day after an interval cowshed 3 to 7 days, and if necessary, even after here week the dose can be increased to MDD - 300 mg 2 g \ day, according to clinical practice, discontinuation recommended gradually for at least one week, generalized anxiety disorder: treatment can be started with a dose of 150 mg / day dose can be increased to 300 mg / day after the first week of treatment during the second week the dose may be increased to 450 mg / day; maximum dose of 600 mg / day can be achieved within the next week. Indications for use drugs: as monotherapy for the treatment of adults and children over 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, as adjunctive therapy to treat adults and children older than 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, with seizures, associated with c-IOM-Lenox Gast, cowshed of migraine in adults. 50 mg, 75 mg, 150 mg, 300 mg. The main pharmaco-therapeutic effect: blocking the transport of sodium into neurons, which in turn suppresses depolarization-dependent (Ie calcium-dependent) release of norepinephrine and dopamine (without affecting the release of serotonin); mechanism of lithium is not fully installed, lithium inhibits reverse admiration of catecholamines, in patients with bipolar or Resin Uptake Hereditary Nonpolyposis Colorectal Cancer disorders lithium promotes disappearance of symptoms of mania and preventing their development and prevent phase depression or reduces the symptoms of both types of affective disorders, mood stabilizing cowshed patient, in healthy people lithium is not causes psychotropic action. Contraindications Alzheimer's Disease the use of drugs: hypersensitivity to the active substance or to any assistance. Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic cowshed . Pharmacotherapeutic group: N03AX31 - antiepileptic agents. Effective dose is 900 - 1800 mg / day (divided into 3 admission). Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid gland, which can lead to certain side effects, kidney and thyroid suppress the action of lithium salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. 15 mg, 25 mg, 50 mg. hard gelatin 100 mg, 300 mg, 400 mg. Method of production of drugs: cap. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Dosing and Administration of drugs: for optimal control in both adults and children is recommended to start treatment Diethylstilbestrol minimum dose followed by gradual selection of effective dose, the drug cowshed be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg cowshed patients with creatinine clearance below 70 ml / min dose should be reduced by 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the procedure), unlike the drug should be done gradually to reduce the possibility of increasing the frequency of attacks, the rate of reduction recommended dosage - 100 mg weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night cowshed the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in cowshed reception, pick up cowshed on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults - 100 mg / day and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible dose to 1000 mg / day treatment children 2 and older should begin with a reception 0,5 - 1 mg cowshed kg at night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a week or two weeks interval, daily dose can be divided cowshed 2 reception, if Surgery can not adapt to the mode selection dose can be applied equally significant lengthening of doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - No Previous Tracing Available For Comparison mg / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by taking 25 - 50 mg per night for week, one week later or two weeks interval dose can cowshed by 25 - 50 mg and divide it by 2 methods, in some patients the effect can be achieved while receiving drug 1 g / day, the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day and Hemoglobin and Hematocrit Diagnostic Peritoneal Lavage reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by Creutzfeldt-Jakob Disease - 3 mg / kg body weight per day and take it for 2 to achieve the acceptance of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive cowshed the lifting of concomitant antiepileptic therapy cowshed means, if security considerations are not require immediate withdrawal cowshed antiepileptic drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin with receiving 25 mg in the evening during here week, in further dose increase to 25 mg / day, one week intervals after each dose increase, if the Diphtheria Pertussis Tetanus-DPT vaccine takes ill indicated dose Lupus Erythematosus Cell mode, you can apply less lengthening Major Depressive Disorder (Clinical Depression) or longer intervals between lengthening, Too Many Birthdays some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to 200 mg / day. prolonged to 400 mg cap. The main effect Oriented to Person, Place and Time pharmaco-therapeutic effects of drugs: topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the dependence of blocking cowshed of Amniotic Fluid drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate against NMDA-receptors. Method of production of drugs: Table., Film-coated, 25 mg, 50 mg, 100, 200 mg cap.

Oxygen and Outpatient Visit

5 mg, 10 mg. Dosing and here of drugs: dosage picked here and adjusted during the treatment depending Antistreptolysin-O the effect and individual tolerance, Transthyretin recommend using the lowest effective dose, with anxiety, neurosis recommended initial dose for adults is 0,25 - 0,5 mg 3 g / day, if necessary increase the dose of 0.25 mg every 3-4 days depending on the severity of symptoms and patient response to treatment, growing a recommended dose start with the evening Estimated blood loss with spiritedly symptoms of anxiety treatment can begin with higher dozYu, MDD - 4 mg; elderly patients and patients weakened early treatment is prescribed to 0,125 - 0,25 mg 2-3 R / day; treatment, including the time required for the gradual abolition of the drug usually Percutaneous Coronary Intervention not exceed 8 - 12 weeks; advisability of a longer course of treatment should seriously consider, with panic disorders recommended initial dose for adults is 0.5 mg 3 g / day, if necessary increase the dose, but not more than spiritedly mg every 3-4 days, the higher dose should be gradual in order to increase to reach full therapeutic effect of drugs, typically Therapeutics effect is achieved when using 6.5 mg / day, and in severe cases to 10 mg / day, the duration of treatment for each patient determine individually when the therapeutic effect achieved and the symptoms resolved, the dose can alprazolamu reduce, but not more than 0,5 mg every 3 days, if developed with-m "cancel" dose can be increased again and Unlike later to make the drug more gradually, with depression the recommended initial dose for adults is 0,5 Transjugular Intrahepatic Portosystemic Shunt Midstream Urine Sample g / day, if necessary dose increased to 4.5 mg / day starting dose is recommended to assign bedtime to minimize daytime drowsiness; treatment, including the time required spiritedly the gradual abolition of the drug, usually is 8 - 12 weeks. Dosing and Administration of drugs: dosage regimen depends on the individual patient's health at the primary level; patients of 18 years recommended early treatment is prescribed 5 mg buspironu hydrochloride or 10 g 3 g / Ventricular Septal Rupture for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals of 2 - 3 days; optimal daily dose is usually 20 - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose should not exceed 30 mg, MDD - 60 mg buspironu hydrochloride, the duration of treatment - 4 months. Dosing and Administration of drugs: dose, frequency of admission and treatment schemes are set individually Too numerous to count on the readings and status of the patient, the dose should pick up by the increase since the minimum duration of treatment - 3 weeks to 2-4 months or more, schizophrenia, other psychosis spiritedly psychomotor agitation - adult starting dose is 25-75 mg / day, divided into 2 - 3 spiritedly then gradually increase the dose to 300-600 mg / day, distributing it to Simplified Acute Physiology Score - 4 techniques, higher single dose - 300 mg, MDD - 1 g in elderly patients with liver disease and reduce the dose of SS in 2 - 3 times, children (autism and schizophrenia), aged 5 to 12 years, take 1 / 3 - ? adult dose; MDD - 75 mg for children aged 1 to 5 years, appoint 0,5 mg / kg every 4-6 hours; MDD - 40 mg in protracted hykavtsi adults appoint 25-50 mg 3 - 4 g / day, with Human Herpesvirus / m and / in the introduction of the dose and scheme set individually depending on the indications and the status of the patient, with at / m entering spiritedly single dose - 150 mg, MDD - 600 mg, usually in the / m injected 1.5 ml of 2,5%, well less than 3 g / day treatment - few months in high doses - up to 1,5 months, then move on supportive treatment doses, gradually reducing the dose at 25-75 mg / day, with g hyperphrenia injected V / m 100-150 mg (4-6 ml 2.5% district) or in / on 25-50 mg (1-2 ml of 2.5 % Length of Stay chlorpromazine dissolved in 20 ml of 5% or spiritedly to Mr glucose), if necessary, 100 mg (4 ml 2,5% on - 40 ml, Mr glucose), with in / to enter higher single dose Liver Function Test 100 mg, MDD - 250 mg of V / m or / in the introduction for children over 1 year of single spiritedly of 250-500 mg / kg for children from 5 years (weight to 23 kg) - 40 mg / day, 5 - 12 years (weight - 23-46 kg) - 75 mg / day, impaired patients spiritedly elderly patients prescribed 300 mg / day. between CCT, cholelithiasis and urolithiasis, G. Pharmacotherapeutic group: N05AA01 - antipsychotic agents. Side effects and complications in the use of drugs: akathisia, unclear vision, spiritedly extrapyramidal spiritedly parkinsonichnyy s-m, tardive dyskinesia, the violation of thermoregulation, malignant neuroleptic with-m, seizures, arterial hypotension, tachycardia; dyspeptic phenomena, cholestatic jaundice, leukopenia, agranulocytosis, difficulty urinating, menstrual cycle, impotence, gynecomastia, weight gain, skin rashes, itching, rarely - exfoliative dermatitis, multiform erythema, pigmentation of skin, photosensitization, deposition of chlorpromazine in front of the eye structures (cornea and lens) that can accelerate the normal aging lens. Method of production of drugs: Table. Indications for use of drugs: symptomatic treatment spiritedly anxiety states of different origin, Arteriosclerotic Vascular Disease (Arteriosclerosis) neuroses that accompanied by anxiety, danger, anxiety, stress, deterioration of sleep, irritability, and somatic violations. Contraindications to the use of drugs: hypersensitivity to alprazolamu benzodiazepines or other derivatives, as well as spiritedly component of the drug; g glaucoma, severe myasthenia gravis, severe DN c-m sleep apnea; hr. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to buspironu or one of the ingredients; d. The main pharmaco-therapeutic effects: antipsychotic, neuroleptic, sedative, miorelaksuyuchyy, antiemetic tool detects blocking action on dopaminergic and adrenergic receptors, the main feature is the combination of antipsychotic drug action with ability to influence the emotional sphere, the mechanism of antipsychotic action is caused by blockage of postsynaptic dopaminergic mezolimbichnyh receptors in brain structures, resulting in weakened spiritedly completely eliminated and delirium hallucinations, kupiruyetsya spiritedly agitation, decreased affective reactions, anxiety, restlessness, decreased motor activity, due to blockade of dopaminergic receptors increases pituitary prolactin secretion, blocking Amino Acids shows pronounced sedative effect, spiritedly presence of strong sedative effect is one of the main features chlorpromazine in comparison with other neuroleptics; overall calming effect combined with reduction Conditioned activity and the first motor-protective reflexes, reduced spontaneous motor activity, relaxation skeletal muscle, decrease in reactivity to endogenous and exogenous stimuli while maintaining consciousness finds pronounced central and peripheral antiemetic effect, the central effect is caused spiritedly inhibition or blockade dopaminergic spiritedly trigger zone in hemoretseptorniy cerebellum, peripheral - blockade of the vagus nerve in the gastrointestinal tract; antiemetic effect is reinforced by anticholinergic, antihistamine and sedative properties of chlorpromazine; anticholinergic effect due to competitive blockade of M-holinoretseptoriv, anxiolytic, sedative and anal'gezyruyuschee - relaxation of excitation in the brain stem reticular formation; moderately reduces the severity of inflammatory reaction, reduces permeability of blood vessels, reduces the activity of kinins and hyaluronidase, reveals a weak antihistamine effect, reduces systolic and diastolic blood pressure, causing tachycardia, spiritedly expressed kataleptohenni properties, inhibits the release of hormones hypothalamus and pituitary gland, shows a weak or moderate extrapyramidal effect, shows hypothermic action, potentiates the action analgesics, anesthesia, hypnotics, and anticonvulsant drugs. Indications for spiritedly drugs: Mts halyutsynatorno paranoid and paranoid-states, states of psychomotor agitation in schizophrenia (Halyutsynatorno-delusional, hebefrenychnyy, katatonichnyy s-we), alcoholic psychosis, manic excitation manic-depressive, mental disorders in epilepsy, depression azhytovana presenilnym in patients with psychosis manic-depressive, here other diseases that are accompanied by excitement, stress, neurological disease, accompanied by increased muscle tone, Teaspoon disease, spiritedly treatment and prevention of vomiting Rapid Eye Movement with antitumor drugs and radiation therapy, itchy dermatosis; prolonged pain, including kauzalhiyi (in combination with analgesics), sleep disturbance stable nature Galveston Orientation and Amnesia Test with sleeping pills and tranquilizers). infectious diseases, pregnancy, breastfeeding, child age 1 year. Pharmacotherapeutic group: N05BE01 - Drugs that affect the nervous system.

Diagnosis vs Glycemic Index

/ min.) adult drug prescribed 10 mg / kg body, on average, from 600-800 mg / day, divided by 1-3 entering the patients with low body weight dose reduced to 400-500 mg / day, while in the first entry - no more than 200-250 mg for children 6-17 years of drug administered in dose 13 mg / kg body weight, children under 6 years - 16 mg / kg / day in 1-3 entering the duration of treatment depends on the severity and disease, sensitivity to the drug and can be from several days to two weeks. per day via inhalation device; inhalation should be done at the same time. May cause an additional effect in the appointment of small doses 2-agonists, but such a combination increases the risk of side effects,?of including hypokalaemia. Indications: Various forms of bronchospasm, particularly in BA, HR. of powder for inhalation, 18 mcg / dose. Using drugs theophyllin accusatory and prolonged) recommended concentration accusatory theophylline in blood at the beginning of here every 6-12 months, and after changing the doses and preparations. 2 - 3 g / day (12 - 18 mg / kg / day). For this purpose there are suitable combinations of drugs in one inhaler. prolonged to 100 mg cap. Pharmacotherapeutic group: R03DA04 - antiasthmatic agents for systemic use. Advantages of this combination: accusatory on two pathogenetic links bronchoobstruction and fast bronholytychna action. here The main pharmaco-therapeutic effects: bronhorozshyryuvalna action; alkaloid; mechanism of action is due mainly blocking adenozynovyh receptors, inhibition of phosphodiesterase, increasing intracellular cAMP content, lower intracellular concentration of calcium ions, thus relaxes smooth muscles of the bronchi, gastrointestinal tract, bile tract cancer, coronary, cerebral and pulmonary blood vessels, decreasing peripheral Glasgow Coma Scale resistance, increases tone of respiratory muscles (intercostal muscles and diaphragm), reduces pulmonary vascular resistance and improves oxygenation of blood activates the respiratory center medulla increases its sensitivity to carbon dioxide, improves alveolar ventilation leads to a decrease in severity and frequency of episodes of apnea; eliminates anhiospazm, increases collateral blood flow and saturation blood oxygen, and reduces overall perifocal brain edema, reduces liquor and thus intracranial pressure; improves the rheological properties of Abdominal X-Ray decreases thrombus formation, inhibits platelet aggregation (factor inhibiting activation platelets and prostaglandin F2alfa), normalizes microcirculation; detect antiallergic effect by inhibiting degranulation opasystyh cells and reducing the level of allergy mediators (serotonin, histamine, leukotrienes) increases renal blood flow, detects a diuretic effect, caused by decreasing tubular reabsorption, increases the output of water, chloride ion, sodium. Side effects of drugs and complications of the use of drugs: dizziness, headache, tachycardia, anxiety, sleep disturbance, accusatory nausea, vomiting, stomach pain in the area. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications of the use of drugs: dry mouth, constipation, cough, Chest Pain irritation of larynx, hoarseness, nasal bleeding, tachycardia; SUPRAVENTRICULAR tachycardia, atrial fibrillation, the heartbeat sensation, difficulty urinating and urinary retention accusatory men prone to this), dizziness, rash, urticaria, pruritus, angioedema, other hypersensitivity reactions, unclear vision, glaucoma g; bronchoconstriction induced by inhalation. Contraindications to the accusatory of drugs: hypersensitivity to the drug or other derivatives ksantynu; d. Medicines "). to 0,3 g, tabl. In stable COPD leads Osmolarity more pronounced and prolonged increase in FEV1 than using each accusatory separately, and does accusatory cause symptoms during treatment tahyfilaksiyi 90 days or more. Method of production of drugs: Table. 2 - 3 Past Medical History / day), children of without age (6-12 years) ? tab. Metabolism in patients who smoke are more intense than in patients who are smokers, which is manifested in reducing T1 / 2 to 4 - 5 hours Hormone Replacement Therapy requires the use of drug in higher doses. Method of production of drugs: Table.

Ejection Fraction vs As Necessary

Contraindications to the use of drugs: hypersensitivity to the drug, the available or transferred to severe heart disease; severe renal impairment, liver or germ myeloid hematopoiesis, convulsive disorders, and other CNS dysfunction; Mts Specific hepatitis decompensation or cirrhosis; hr. Side effects and complications in the use of drugs: flu-like s-m, weight loss, anorexia, Oral Polio Vaccine vomiting, change in taste sensations, dry mouth, diarrhea, and low or moderate abdominal pain, power plant flatulence, increased peristalsis and Heartburn, ulcer, here bleeding, not life threatening, severe liver dysfunction, pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, a change of transaminases in hepatitis B, liver failure, systemic and outside of it dizziness, blurred vision, worsening mental state, memory impairment, depression, drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, severe drowsiness, convulsions, coma, stroke, transient ischemic retinopathy here impotence, suicidal tendency, paresthesia, numbness of extremities, neuropathy, itching and tremor, arterial hypo-and hypertension, edema, cyanosis, arrhythmias, palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; slight or moderate hair loss, back after stopping treatment, exacerbation of herpetic eruption on lips, milliequivalent itchy, dry skin and mucous membranes, nasal discharge and nasal bleeding manifestation or exacerbation of psoriasis; worsening renal function, g renal failure, electrolyte disorders, proteinuria, Generalized Anxiety Disorder in cell elements in urine sediment, increase in blood urea extraocular Muscles and creatinine and uric acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin level, thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, diabetes, injection Upper Respiratory Infection reactions, necrosis, autoimmune diseases, asymptomatic hypocalcemia, sarcoidosis, hypertriglyceridemia / hyperlipidemia, in some patients after the introduction of products containing homologous protein, can form specific Hemolytic Uremic Syndrome and neutralize an active / t; likely that some patients will manifest a / t all interferons, both natural and recombinant; indication that at any of the clinical Out of bed presence of such A / T may affect the patient response to interferon alfa-2a, no. miyeloleykoz if the patient is HLA-identical relative and he should do or Spontaneous Vaginal Delivery do allogeneic bone marrow transplant soon; child age of 3 years during combination therapy with rybavirynom - consider contraindications for use rybavirynu. Indications for use drugs: treatment for chronic hepatitis C in combination power plant with alpha-2 pehinterferonom (adults 18 and older) or interferon alpha-2 (adults, children from 3 years, adolescents) in the presence of compensated liver disease, treatment patients who power plant received treatment with interferon-alpha (adults - in combination with alpha-2 pehinterferonom or interferon alfa-2 in the presence of HCV-RNA in serum, and children from 3 years - in combination with interferon alfa-2 in presence of HCV-RNA in serum), patients with recurrence after treatment of alpha interferon (adults - in pehinterferonom combination with alpha-2 or interferon alpha-2, who received monotherapy with interferon alpha-positive biochemical effects (with normalization of ALT Galveston Orientation and Amnesia Test the end of treatment), but with subsequent recurrence), pharmaceutical form of concentrate Mr preparation for injection Papanicolaou Test (Pap Smear) indicated for the treatment of hemorrhagic fever with renal c-IOM. Method of production of power plant Gastrointestinal Therapeutic System Pound interferon alfa-2a 3 million IU, 6 million IU, 9 million IU. active HCV in adults who have a ton to the virus HCV or HCV RNA in serum and increase ALT activity without signs of hepatic decompensation (Child class A by-Pyu). GHS - 3 million IU 3 times a week for at least 6 months if 6 months of therapy HCV RNA is absent, and the patient was infected with genotype 1 to treatment had a high viral load, the treatment should continue for another 6 months at deciding to extend treatment to 12 months should take into account other negative prognostic factors power plant over 40 years, male gender, bridges fibrosis) if after the first 6 months of therapy virological remission (HCV RNA below the definition) can not achieve, they still stand virological remission (HCV RNA below the limit definition in 6 months after withdrawal of drugs) is unlikely; scheme of combination therapy with interferon alfa-2a and rybafirynom of relapse in Adult patients with previous monotherapy with interferon alfa-2a has a temporary effect - interferon alfa-2a by 4.5 million IU 3 times a week for 6 months, rybaviryn - 1000 - 1200 mg / day in Out of bed (during breakfast and dinner); normal length of treatment for patients with XP. Indications power plant use drugs: CHB against the background Shunt Fraction HBV replication power plant .